APA (7th ed.) Citation

T, Y., S, S., K, O., K, T., T, K., K, K., . . . M, I. (2024). Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): A phase 2, randomized, double-blinded, placebo-controlled, clinical trial. EClinicalMedicine, 77, 102901. https://doi.org/10.1016/j.eclinm.2024.102901

Chicago Style (17th ed.) Citation

T, Yoshimoto, et al. "Efficacy and Safety of Adrenomedullin for Acute Ischemic Stroke (AMFIS): A Phase 2, Randomized, Double-blinded, Placebo-controlled, Clinical Trial." EClinicalMedicine 77 (2024): 102901. https://doi.org/10.1016/j.eclinm.2024.102901.

MLA (9th ed.) Citation

T, Yoshimoto, et al. "Efficacy and Safety of Adrenomedullin for Acute Ischemic Stroke (AMFIS): A Phase 2, Randomized, Double-blinded, Placebo-controlled, Clinical Trial." EClinicalMedicine, vol. 77, 2024, p. 102901, https://doi.org/10.1016/j.eclinm.2024.102901.